Patents by Inventor Yanping Wang

Yanping Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11991914
    Abstract: Disclosed in the present disclosure are a transparent display panel and a display device, used for prolonging the service life of an electroluminescent device in the transparent display panel. According to the transparent display panel provided by the embodiment of the present disclosure, the transparent display panel is divided into a display area arranged in an array and a light-transmitting area surrounding the display area; the display area comprises a transparent substrate, an electroluminescent device positioned on the transparent substrate, and a light blocking part located on the side of the transparent substrate deviating from the electroluminescent device; the light blocking part is used for blocking light entering from the side of the transparent substrate deviating from the electroluminescent device to irradiate the electroluminescent device.
    Type: Grant
    Filed: May 9, 2020
    Date of Patent: May 21, 2024
    Assignees: Chengdu BOE Optoelectronics Technology Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Yanping Ren, Yudan Shui, Wenkang Wang
  • Publication number: 20240153965
    Abstract: A display panel, a method for driving the display panel, and a display device are provided. In an embodiment, the display panel includes: a first substrate; a display dielectric layer located at a side of the first substrate; pixel electrodes and peek-proof electrodes, all of the pixel electrodes and the peek-proof electrodes being arranged between the first substrate and the display dielectric layer; and a light-shielding structural layer including a light-shielding structure and a hollow-out portion. In an embodiment, along a direction perpendicular to a plane of the display panel, the peek-proof electrodes overlap with the light-shielding structure, and the pixel electrodes overlap with the hollow-out portion; and the light-shielding structural layer is located at a side of the peek-proof electrodes adjacent to a light exit surface of the display panel.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 9, 2024
    Applicant: Xiamen Tianma Micro-Electronics Co., Ltd.
    Inventors: Meihong LIN, Yuchao WANG, Yanping YU
  • Publication number: 20240122875
    Abstract: Provided is a use of a mitoxantrone hydrochloride liposome in the preparation of a drug for treating urothelial cancer, breast cancer, and bone and soft tissue sarcoma. Further provided is a method for treating urothelial cancer, breast cancer, and bone and soft tissue sarcoma, and the method is to administer a therapeutically effective amount of mitoxantrone hydrochloride liposomes to a patient in need. The mitoxantrone hydrochloride liposome can effectively treat urothelial cancer, breast cancer, and bone and soft tissue sarcoma, and compared with common mitoxantrone hydrochloride injections, the mitoxantrone hydrochloride liposome has better therapeutic effect and fewer adverse reactions.
    Type: Application
    Filed: April 15, 2022
    Publication date: April 18, 2024
    Inventors: Chunlei LI, Yanping LIU, Min LIANG, Mengmeng LI, Tong LI, Hua YANG, Shixia WANG, Sensen YANG
  • Publication number: 20240117520
    Abstract: The present disclosure discloses a gradient single-crystal positive electrode material, which has a chemical formula of LiNixCoyA1-x-yO2@mLiaZbOc, wherein 0<x<1, 0<y<1, 0<x+y<1, 0<m<0.05, 0.3<a?10, 1?b<4, and 1?c<15, A is at least one of Mn, Zr, Sr, Ba, W, Ti, Al, Mg, Y, and Nb, and Z is at least one of B, Al, Co, W, Ti, Zr, and Si. The atomic ratio of the content of Co on the surface of the single-crystal positive electrode material particle to the content of Ni+Co+A on the surface is greater than 0.4 and less than 0.8, and the atomic ratio of Co at a depth 10% of the radius from the surface of the single crystal positive electrode material particle is not less than 0.3; and the single-crystal positive electrode material particle has a roundness of greater than 0.4, and is free from sharp corners.
    Type: Application
    Filed: November 11, 2022
    Publication date: April 11, 2024
    Inventors: Jinsuo LI, Di CHENG, Yunjun XU, Gaofeng ZUO, Jing HUANG, Xiaojing LI, Danfeng CHEN, Wanchao WEN, Yanping WANG, Zhengzhong YIN
  • Publication number: 20240116909
    Abstract: Compounds of general Formula I, II, III, IV, V and their pharmaceutically acceptable salts, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are synthesis, compositions, and uses of such compounds.
    Type: Application
    Filed: March 29, 2022
    Publication date: April 11, 2024
    Inventors: Yang YE, Xiuwei LI, Guiqun YANG, Fashun YAN, Yanping WANG, Wei LONG
  • Patent number: 11939578
    Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: March 26, 2024
    Inventors: Yanping Zhao, Hongjun Wang, Yuanyuan Jiang, Weiting Zhong, Jianmei Pang, Gong Li, Xiang Li, Yixin He, Liying Zhou, Yanan Liu
  • Patent number: 11939307
    Abstract: Disclosed are a benzyl piperazine compound, a preparation method there for and an application thereof in an antivirus. The benzyl piperazine compound has a structure represented by the following general formula(I). It is proven by experiments that the benzyl piperazine compound not only has significant antiviral activity, but also has the advantages of low cytotoxicity, a high selectivity index and soon.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: March 26, 2024
    Inventors: Yanping Li, Zhuorong Li, Zonggen Peng, Xinbei Jiang, Yixuan Wang, Jianrui Li, Jiali Tan
  • Publication number: 20240096902
    Abstract: The dual gate array substrate of the present disclosure includes a plurality of groups of dual gate lines, a plurality of data lines, a plurality of pixel pairs and a plurality of common electrode lines, each common electrode line is arranged between two pixel units in a same pixel pair and is connected to common electrodes of the two pixel units through two first vias; a layer where the common electrode line is located and a layer where a source/drain electrode of a thin film transistor is located are different layers and insulated from each other; the two first vias are on both sides of the data line.
    Type: Application
    Filed: April 27, 2021
    Publication date: March 21, 2024
    Inventors: Cong WANG, Yingmeng MIAO, Dongchuan CHEN, Seungmin LEE, Yanping LIAO, Xibin SHAO, Jiantao LIU
  • Patent number: 11919918
    Abstract: A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drug for preventing or treating a disease mediated by the P2X3 and/or P2X2/3 receptor antagonist.
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: March 5, 2024
    Inventors: Yanping Zhao, Hongjun Wang, Gong Li, Xiang Li, Yuanyuan Jiang, Kai Liu, Yeming Wang, Liying Zhou, Yanan Liu, Ning Shao, Fengping Xiao
  • Publication number: 20240072340
    Abstract: A battery housing includes a plate body. The plate body has multiple folding portions and multiple side plates connected by the folding portions. The plate body is folded along the folding portions such that the side plates are connected to create an accommodating space for accommodating an electrochemical unit inside the middle housing.
    Type: Application
    Filed: November 3, 2023
    Publication date: February 29, 2024
    Inventors: Yanping LUAN, Liangliang GU, Bing WANG, Yanwei WEI
  • Publication number: 20240025922
    Abstract: Tetrahydropyrido[3,4-d]pyrimidines compounds are provided that are potent HPK1 inhibitors. The compounds are useful to treat or prevent cancer and/or inflammatory and/or autoimmune diseases or symptoms thereof in mammals, particularly humans. The compounds have a chemical structure of the general Formula (I), (II), (III), (IV) or (V) or enantiomers or diastereomers or mixtures thereof or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: May 8, 2023
    Publication date: January 25, 2024
    Inventors: Momar TOURE, Bin LI, Constantin NEAGU, Yanping WANG, Theresa JOHNSON, Andrea UNZUE LOPEZ, Yufang XIAO, Emily FRIIS, Maria DIPOTO, Satenig GULER
  • Publication number: 20240004730
    Abstract: An event processing method provided by an embodiment of the present disclosure determines M events, where each event is associated with a priority and a minimum working time, M is an integer greater than 1, and the minimum working time of each event is less than duration of a time slice; processes a first event within a first time slice, where the first event is an event having a highest priority among the M events; and in the case that processing duration of the first event reaches the minimum working time of the first event, determines to continue to process the first event within the first time slice, or determines to interrupt processing of the first event and processes a second event within the first time slice.
    Type: Application
    Filed: October 27, 2021
    Publication date: January 4, 2024
    Applicant: Spreadtrum Communications (Shanghai) Co., Ltd.
    Inventors: Yanping WANG, Zhiwen LIU, Ling ZHOU, Wei LU
  • Publication number: 20230399297
    Abstract: The invention relates to novel glutamine analogs, a composition containing the glutamine analogs and the use thereof.
    Type: Application
    Filed: October 14, 2021
    Publication date: December 14, 2023
    Inventors: Runze LI, Cunbo MA, Zhenchang LIAN, Jing XIONG, Yanping WANG, Wei LONG
  • Publication number: 20230357410
    Abstract: The present invention provides recombinant bispecific antibodies designed to bind to a surface antigen on target cells and to an activating component on immune cells such as T cells. The bispecific antibodies comprise two polypeptide chains that contain Fv and Fab as antigenĀ¬ binding fragments and a modified Fc region to facilitate heterodimer formation. In one embodiment, the bispecific antibodies further comprise protease cleavage sites and/or motifs that would cause steric occlusion of the antigen binding sites so that the antibodies would be activated only in a specific environment, e.g. in the vicinity of a tumor. In another embodiment, the bispecific antibodies comprise modified sequences that confer reduced binding affinity to CDS and/or cross-reactive binding to CDS on cells from different species.
    Type: Application
    Filed: December 20, 2019
    Publication date: November 9, 2023
    Applicant: Zhejiang Shimai Pharmaceutical Co.,Ltd.
    Inventors: Weizao Chen, Yanping Wang, Zuoxiang Xiao
  • Publication number: 20230311668
    Abstract: Proposed are a synchronous braking control method and system for carriages of a train, that are related to the field of electrical control. The synchronous braking control system includes a main controller, an electric energy conversion controller, and a shunt. During actual braking, the main controller obtains a real-time speed and real-time mass of the train, and determines whether the real-time speed is greater than a set speed. If not, the train is directly braked in a mechanical friction braking mode. If yes, an exciting current of a synchronous brake in each of the carriages of the train is adjusted by adjusting an input voltage of the synchronous brake, and unit braking forces of the carriages are controlled equal by using the adjusted exciting current, thereby realizing synchronous constant deceleration braking of the carriages.
    Type: Application
    Filed: November 19, 2021
    Publication date: October 5, 2023
    Inventors: Yanping WANG, Zhisen WANG, Shixuan CUI
  • Patent number: 11765997
    Abstract: The application provides a method for improving nutrient supply of female floral branches of Populus deltoides artificial hybridization. According to the technical links of the hybridization operation, the method separately integrates and improves the cultivation of female floral branch nutrient-supply seedlings (i.e., grafting rootstocks of floral branches), the pre-management of female floral branch nutrient-supply seedlings, the hydroponic management of floral branches, the Marching between female floral branches and rootstocks, the management of female floral branch nutrient-supply seedlings and the hydroponic management of female floral branches, so the goal of improving the seed-setting rate and quality of poplar hybrid seeds which came from the floral branches cultured in water has been achieved.
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: September 26, 2023
    Assignee: Research Institute of Forestry Chinese Academy of Forestry
    Inventors: Changjun Ding, Yufeng Dong, Weixi Zhang, Xiaohua Su, Shanwen Li, Yanping Wang, Qinjun Huang, Lei Wang
  • Patent number: 11702392
    Abstract: The invention relates to pyrimidinone derivatives of the general Formula I, or a pharmaceutically acceptable salt thereof, and the use of the compounds of the present invention for the treatment of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: July 18, 2023
    Assignee: Merck Patent GmbH
    Inventors: Catherine Jorand-Lebrun, Roch Boivin, Theresa Johnson, Yanping Wang, Yufang Xiao, Xiaoling Chen, Nina Linde, Doreen Musch, Deepak Kumar
  • Publication number: 20230201119
    Abstract: Provided are a liposome containing Eribulin or a pharmaceutically acceptable salt thereof and a preparation method therefor. An inner aqueous phase of the liposome contains Eribulin or a salt thereof, and one or more selected from ethylenediamine tetraacetic acid, phosphoric acid, pentetic acid, or salts thereof. Further provided are a pharmaceutical composition containing the aforementioned liposome and a preparation method therefor.
    Type: Application
    Filed: May 28, 2021
    Publication date: June 29, 2023
    Inventors: Xinyong TONG, Aifeng ZOU, Qibo ZHANG, Dan LIU, Zhonghua MA, Yanping WANG
  • Patent number: 11581503
    Abstract: Provided is a light-emitting diode and a method for preparing the same. The light-emitting diode includes an anode, a hole transport layer, a perovskite light-emitting layer, an electron transport layer and a cathode stacked in sequence, in which the perovskite light-emitting layer includes a first sublayer and a second sublayer stacked in sequence, with a material for forming the first sublayer including an inorganic perovskite material, and with a material for forming the second sublayer being an organic perovskite material.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: February 14, 2023
    Inventors: Ruipeng Xu, Lifu Wang, Yanping Wang, Peng Zhou
  • Patent number: 11466005
    Abstract: Disclosed are tricyclic compounds as bromodomain and extra-terminal (BET) inhibitors which are shown as formula I, their synthesis and their use for treating diseases. More particularly, disclosed are fused heterocyclic derivatives useful as inhibitors of BET, methods for producing such compounds and methods for treating diseases and conditions wherein inhibition of one or more BET bromodomains provides a benefit.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: October 11, 2022
    Inventors: Haiquan Fang, Mingming Chen, Guiqun Yang, Yuelei Du, Yanping Wang, Tong Wu, Qinglong Li, Lei Zhang, Shaojing Hu